Live Breaking News & Updates on சிப்லா பகிர் ப்ரைஸ்
Stay updated with breaking news from சிப்லா பகிர் ப்ரைஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The second batch of the antibody cocktail will be made available by mid-June, Cipla added Cipla and Roche India have launched Roche India s antibody drug cocktail in India for treating mild to moderate COVID-19 cases. Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla said in a regulatory filing to the stock exchanges. The second batch of the antibody cocktail will be made available by mid-June, Cipla added. Umang Vohra, Managing Director and Global CEO, Cipla said, We are guided by our strong sense of responsibility to address unmet patient need and look forward to leveraging our solid marketing and distribution strengths in India to provide broader, equitable access to this innovative treatment option in the country . ....
ViraGen used for qualitative detection of SARS-CoV-2 will be manufactured by Ubio Biotechnology Systems. Shares of the country s leading drug maker - Cipla - rose as much as 2.63 per cent to hit an intraday high of Rs 927.85 after the company launched Coronavirus detections test kit. Cipla announced the commercialization of a polymerase chain reaction (RT-PCR) test kit ViraGen for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla s third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits, Cipla said in a press release. ViraGen is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology. It helps to identify and detect SARS CoV-2 N Gene and ORF Lab Gene with the sensitivity of 98.6 per cent and the specificity of 98.8 per cent as compared to a standard ICMR test. ....
Explore Now Nifty futures on the Singapore Exchange traded 161 points, or 1.08 per cent, higher at 15,114.50 in signs that Dalal Street was headed for a gap-up start on Monday. Here are a few stocks which may buzz the most in today s trade: Adani Power: The company has made a Rs 2,600-crore offer to acquire Essar Power MP under the Insolvency and Bankruptcy Code (IBC) rules, according to multiple sources. Mphasis: Negotiations between Blackstone Group and Carlyle for the biggest technology takeover in India have hit a bump as Mphasis share price continues to soar, people involved in the matter said. PVR: Multiplex major ....
Here are the key stocks to track in today s session: TCS: Information technology stocks would remain under investor radar on Monday after IT major Tata Consultancy Services on Friday posted a 7.18 per cent year-on-year (YoY) rise in its December quarter (Q3FY21) profit at Rs 8,701 crore. TCS also announced third interm dividend of Rs 6 per share. Avenue Supermarts: Avenue Supermarts, which owns and operates retail chain D-Mart, on Saturday reported an increase of 16.39 per cent in its consolidated net profit at Rs 446.95 crore for the third quarter ended December 2020. Wipro: The Rs 9,500-crore buyback offer from Wipro will end today. The offer received overwhelming response from investors on Friday, and has been subscribed 326.45 per cent, as per reports. The firm, which proposed to buyback 23.75 crore shares at Rs 400 a share, has received bids for 77.53 crore shares. ....